Related Experiment Video
Updated: Aug 10, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes
Sarah Gilligan1, Kalani L Raphael1
1Division of Nephrology, Department of Medicine, University of Utah, Salt Lake City, UT; and Nephrology Section, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT.
Insights
Serum potassium abnormalities, including hyperkalemia and hypokalemia, are common in chronic kidney disease (CKD). Both conditions increase risks for death and cardiovascular disease, with hypokalemia potentially worsening CKD progression.
Area of Science:
- Nephrology
- Internal Medicine
- Cardiology
Background:
- Serum potassium abnormalities are frequent in patients with chronic kidney disease (CKD).
- Hyperkalemia is a recognized complication, but hypokalemia occurs with similar prevalence (12%-18%) compared to hyperkalemia (14%-20%).
Purpose of the Study:
- To review the prevalence and risk factors for hyperkalemia and hypokalemia in CKD patients.
- To examine the associations between these potassium imbalances and adverse outcomes in CKD.
Main Methods:
- Literature review of studies on serum potassium levels in CKD.
- Analysis of factors influencing serum potassium, including CKD severity, medications (RAAS inhibitors, diuretics), and diet.
- Evaluation of associations with mortality, cardiovascular disease, hospitalization, and CKD progression.
Main Results:
- Both hyperkalemia and hypokalemia are linked to increased risks of death, cardiovascular disease, and hospitalization.
- Limited evidence suggests hypokalemia, but not hyperkalemia, may be associated with CKD progression.
Conclusions:
- Serum potassium monitoring and management are crucial in CKD patients due to similar prevalence of hyperkalemia and hypokalemia.
- Both conditions carry significant risks, highlighting the need for comprehensive patient assessment and intervention strategies.
Abstract:
Abnormalities of serum potassium are common in patients with CKD. Although hyperkalemia is a well-recognized complication of CKD, the prevalence rates of hyperkalemia (14%-20%) and hypokalemia (12%-18%) are similar. CKD severity, use of medications such as renin-angiotensin-aldosterone system inhibitors and diuretics, and dietary potassium intake are major determinants of serum potassium concentration in CKD. Demographic factors, acid-base status, blood glucose, and other comorbidities contribute as well. Both hyperkalemia and hypokalemia are associated with similarly increased risks of death, cardiovascular disease, and hospitalization. On the other hand, limited evidence suggests a link between hypokalemia, but not hyperkalemia, and progression of CKD. This article reviews the prevalence rates and risk factors for hyperkalemia and hypokalemia, and their associations with adverse outcomes in CKD.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management

